It has been a big day at Stanford with genomics, not only was the announcement made to better use sequencing to predict 
own syndrome, but they are also just about ready to receive their new genomic sequencing machine from Helicos. Earlier this year I interviewed Dr. Patrice Milos, Chief Science Officer at Helicos and one of the questions I posed was relative to who their potential clients would be and one answer was universities, for use with research and development and here we have Stanford up and ready to go with the single sequencing machine. 
From the interview: Beyond the services offered by the analysis firms, universities and anyone involved in genomic research is certainly a target market for us to provide the products and software to make it all happen. It's a very fast paced world growing today that is not only impacting the way medicine is practiced, but how we live our lives.
They also received a 75 million dollar contribution today, also relative to genomic research with stem cells for construction of a new facility dedicated to research.
‘The modern, four-story building along Campus Drive will house 350 scientists working together to capture the power of these cells in treating diseases as diverse as cancer, diabetes and heart disease.'’
Proteins also look very cool on Microsoft Surface as well.
After this series of events it apparent that Stanford is setting up to be a major research and development area for biotech and sequencing research. BD
NEW YORK (GenomeWeb News) - Helicos BioSciences said today that it has shipped a Helicos Genetic Analysis System to Stanford University, marking the company’s second shipment to a customer site.
Helicos said in August that it had received an order from a US cancer research center that will use the instrument for research into cancer stem cell biology. A company spokesperson told GenomeWeb Daily News sister publication In Sequence today that this order came from Stanford University.
NEW YORK (GenomeWeb News) – Using shotgun sequencing, researchers from Stanford University and the Howard Hughes Medical Institute have developed a way to test for fetal chromosomal abnormalities, including Down syndrome, based on a mother’s blood sample.
Quake said the team also plans to test the method using other sequencing technologies as well, including the Helicos BioSciences platform, which relies on a single-molecule sequencing approach that Quake helped to pioneer.
Quake, who is also a founder of and consultant for Fluidigm, has applied for a patent related to the methodology outlined in the paper, along with lead author Christina Fan, a bioengineering graduate student at Stanford University. Quake could not disclose who potential licensees of the technology might be.
http://www.genomeweb.com/issues/news/149883-1.html?CMP=OTC-RSS
0 comments :
Post a Comment